Data protection Impressum

Biotech

HAYA Therapeutics, a precision medicine company based at Biopôle in Lausanne, has closed a USD 65 million Series A funding round to accelerate the clinical development of its RNA-guided therapies and expand its regulatory genome platform.

HAYA Therapeutics raises USD 65 million to advance RNA-guided therapies for chronic disease

12 May 2025

The latest edition of the Swiss Biotech Report underscores the continued growth and resilience of Switzerland’s biotech sector, attributing success to strong international collaborations and innovative advancements that promise to reshape healthcare worldwide.

The Swiss biotech industry: building resilience through global alliances

6 May 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (April 2025)

23 April 2025

From clinical research to international leadership, Incyte’s steady growth in Western Switzerland showcases the region’s strength in biopharmaceutical innovation.

Incyte, a key player in Western Switzerland’s biopharmaceutical innovation landscape

A collaborative research team from EPFL, the University of Geneva (UNIGE), and Geneva University Hospitals (HUG) has been awarded the 2025 Leenaards Science Prize for a pioneering project aimed at enhancing the effectiveness of immunotherapy by altering the mechanical properties of cancer cells.

Western Switzerland research teams explore new strategy to boost cancer immunotherapy

14 April 2025

Medtech start-up Novigenix has received EUR 1.8 million from the EU’s Innovative Health Initiative to support the industrialization of its AI-driven liquid biopsy platform as part of a major international cancer research collaboration.

Novigenix secures EUR 1.8 million to scale precision oncology platform

9 April 2025

The 10th edition of BioInnovation Day gathered more than 250 life sciences stakeholders at Campus Biotech in Geneva. Two standout projects, Artiria Medical and Reverso Therapeutics, were honoured for their innovative contributions to stroke treatment and cardiovascular medicine.

Artiria Medical and Reverso Therapeutics awarded at BioInnovation Day 2025

4 April 2025

In a significant step toward future pandemic preparedness, researchers at the University of Bern have uncovered a new mechanism by which coronaviruses manipulate human cells to replicate, offering a promising target for broad-spectrum antiviral therapies.

University of Bern researchers identify promising new strategy against coronaviruses

1 April 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (March 2025)

26 March 2025

A team of researchers from the University of Bern and Japan’s RIKEN Institute has achieved a major breakthrough in sustainable chemistry by developing a novel method to synthesize organic molecules using sodium and iron—two abundant, non-toxic metals. The innovation could pave the way for more environmentally friendly production of pharmaceuticals and fine chemicals.

The University of Bern and RIKEN develop greener chemistry for pharmaceutical production

25 March 2025

1 2 3 4 5 6 7 8 … 23